LYMPHOMAS NON-HODGKIN'S B-CELL
Clinical trials for LYMPHOMAS NON-HODGKIN'S B-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMAS NON-HODGKIN'S B-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMAS NON-HODGKIN'S B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time infusion aims to fight tough blood cancers from within
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new, one-time gene therapy called INT2104 for adults with B-cell blood cancers that have returned or not responded to prior treatments. The therapy is designed to instruct the body's own immune cells to find and fight cancer …
Matched conditions: LYMPHOMAS NON-HODGKIN'S B-CELL
Phase: PHASE1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Feb 23, 2026 14:57 UTC
-
15-Year watch: tracking cancer patients after revolutionary cell therapy
Knowledge-focused Recruiting nowThis study aims to monitor the long-term health of 500 patients who have already received CAR-T cell therapy for various blood cancers in earlier trials. Researchers will follow these patients for up to 15 years to check for any late-developing side effects, such as new cancers o…
Matched conditions: LYMPHOMAS NON-HODGKIN'S B-CELL
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC